CanSino: Convidecia

Vaccine Type: Non Replicating Viral Vector

This vaccine may also be referred to as Ad5-nCoV

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 4 Trials

Phase 2: 6 Trials

Phase 3: 3 Trials

Registered Trials